E17* (p.Glu17Ter) variant of E2F1 (Transcription factor E2F1)
E17* (p.Glu17Ter) in E2F1 (Transcription factor E2F1) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.65 / 1. The record also includes population frequency data.
E17* (p.Glu17Ter) variant details
- p.Glu17Ter
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.648
- CADD 34.00
- UniProt: Variant assessed as somatic; high impact.
- Population evidence available